Search

everythinglearnresearchcommunity

for

Search:↓

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

A patient with complete hair loss regrew all her hair using tofacitinib.

Insulin helps heal corneal wounds and nerves in diabetic mice by activating the Wnt signaling pathway.

Hormones and genes affect hair growth and male baldness.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Topical rapamycin may effectively treat fibrous papules on the face.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

A woman's hair turned white after taking a cancer drug called dasatinib.

Stinging nettle has compounds that help with joint pain, arthritis, and prostate issues.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Organoids can revolutionize medicine by modeling diseases and aiding in personalized treatments.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Proper scalp care can improve hair health and delay ageing signs.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Citrullus colocynthis and Citrullus lanatus have potential health benefits but may also cause reproductive toxicity.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.